Home > Financial Ratios > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Working Capital/Sales(x) 2.432.559.741.581.84

What is the latest Working Capital/Sales ratio of KILITCH DRUGS (INDIA) ?

The latest Working Capital/Sales ratio of KILITCH DRUGS (INDIA) is 2.43 based on Mar2023 Consolidated results.
Year Working Capital/Sales
Mar20232.43
Mar20222.55
Mar20219.74
Mar20201.58
Mar20191.84

How is Working Capital/Sales of KILITCH DRUGS (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2023 2.43
-4.71
Mar2022 2.55
-73.82
Mar2021 9.74
516.46
Mar2020 1.58
-14.13
Mar2019 1.84 -

Other Financial Ratios of KILITCH DRUGS (INDIA)


Compare Working Capital/Sales ratio of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹579.7 Cr 3% -7.7% 114.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

3%

-7.7%

114.5%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses